The following is a summary of “Association between incretin-based drugs and risk of cholangiocarcinoma among patients with ...
During JPM week, virtual care companies strut their plans to make GLP-1 drugs work harder, cost less
Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health ...
In a large population of people with diabetes, the use of GLP-1 receptor agonists was not linked to an increased risk for ...
Health and Me on MSN10h
US Doctor Claims Weight Loss Drug, GLP-1, Leads To Suicidal Thoughts And BehaviorsA study found that disruptions in homeostasis from quick weight reduction by consuming GLP-1 drug can elevate cortisol - a ...
Korea Joongang Daily on MSN11h
Hanmi seeks to gain on Wegovy with its own weight-loss drugHanmi Pharmaceutical Senior Vice President Choi In-young, head of the R&D center, speaks to Korean media outlets at a press ...
The weight-loss succession race is heating up. Here's how biopharma execs talked up those efforts at JPM this week.
Semaglutide (known by its brand name Ozempic) has gained widespread attention for its weight-loss benefits, but is officially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback